insights_auto
Outlook: 79.0% bullish·0.0% bearish
Go to analysischevron_right
HAE:NYSE
Haemonetics Corp
$118.69
arrow_downward
-0.65%(-0.78) 1D
$124.27
arrow_upward
+4.70% (+5.58)bedtimeAfter hours
Closed: Oct 9, 4:00:04 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
Analyst ratings
Based on 9 analysts giving stock ratings to HAE in the past 3 months
Strong buy
Buy
7
Hold
2
Sell
0
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for HAE in the last 3 months.
Highest
Current $118.69
$140.00 (+17.95%)
Average
$125.38 (+5.64%)
Lowest
$86.00 (-27.54%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Anthony Petrone Mizuho Securities | Buy | Maintained | $140.00 | +18% | 10/09/2026 |
Michael Petusky Barrington | Buy | Maintained | $140.00 | +18% | 10/09/2026 |
Travis Steed Bank of America Securities | Buy | Reiterated | $140.00 | +18% | 10/08/2026 |
Marie Thibault BTIG | Buy | Reiterated | $130.00 | +9.5% | 10/08/2026 |
Joanne Wuensch Citi | Buy | Upgraded | $123.00 | +3.6% | 09/18/2026 |
Andrew Cooper Raymond James | Buy | Maintained | $125.00 | +5.3% | 09/03/2026 |
David Rescott Robert W. Baird | Buy | Maintained | $119.00 | +0.3% | 08/21/2026 |
Michael Matson Needham | Hold | Maintained | - | - | 08/18/2026 |
Allen Gong J.P. Morgan | Hold | Maintained | $86.00 | -27.5% | 08/10/2026 |
Rohin K Patel J.P. Morgan | Hold | Reiterated | $62.00 | -47.8% | 05/08/2026 |